IBDEI14H ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20112,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,20113,0)
 ;;=788.31^^131^1284^62
 ;;^UTILITY(U,$J,358.3,20113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20113,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,20113,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,20113,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,20114,0)
 ;;=788.20^^131^1284^63
 ;;^UTILITY(U,$J,358.3,20114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20114,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,20114,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,20114,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,20115,0)
 ;;=112.2^^131^1284^66
 ;;^UTILITY(U,$J,358.3,20115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20115,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,20115,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,20115,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,20116,0)
 ;;=600.01^^131^1284^5
 ;;^UTILITY(U,$J,358.3,20116,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20116,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,20116,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,20116,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,20117,0)
 ;;=600.10^^131^1284^40
 ;;^UTILITY(U,$J,358.3,20117,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20117,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,20117,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,20117,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,20118,0)
 ;;=585.9^^131^1284^8
 ;;^UTILITY(U,$J,358.3,20118,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20118,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,20118,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,20118,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,20119,0)
 ;;=788.64^^131^1284^59
 ;;^UTILITY(U,$J,358.3,20119,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20119,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,20119,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,20119,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,20120,0)
 ;;=788.65^^131^1284^52
 ;;^UTILITY(U,$J,358.3,20120,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20120,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,20120,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,20120,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,20121,0)
 ;;=600.00^^131^1284^4
 ;;^UTILITY(U,$J,358.3,20121,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20121,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,20121,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,20121,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,20122,0)
 ;;=599.70^^131^1284^20
 ;;^UTILITY(U,$J,358.3,20122,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20122,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,20122,1,5,0)
 ;;=5^Hematuria
 ;;^UTILITY(U,$J,358.3,20122,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,20123,0)
 ;;=599.71^^131^1284^21
 ;;^UTILITY(U,$J,358.3,20123,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20123,1,4,0)
 ;;=4^599.71
 ;;^UTILITY(U,$J,358.3,20123,1,5,0)
 ;;=5^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,20123,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,20124,0)
 ;;=599.72^^131^1284^22
 ;;^UTILITY(U,$J,358.3,20124,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20124,1,4,0)
 ;;=4^599.72
 ;;^UTILITY(U,$J,358.3,20124,1,5,0)
 ;;=5^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,20124,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,20125,0)
 ;;=596.89^^131^1284^12
 ;;^UTILITY(U,$J,358.3,20125,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20125,1,4,0)
 ;;=4^596.89
 ;;^UTILITY(U,$J,358.3,20125,1,5,0)
 ;;=5^Cystocele
 ;;^UTILITY(U,$J,358.3,20125,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,20126,0)
 ;;=596.81^^131^1284^15
 ;;^UTILITY(U,$J,358.3,20126,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20126,1,4,0)
 ;;=4^596.81
